出生前検査の世界市場

世界の出生前検査の市場規模は、2023年の109億米ドルから、予測期間中は12.6%のCAGRで推移し、2028年末には198億米ドルの規模に成長すると予測されています。

製品タイプ別では、消耗品の部門は、2023年の63億米ドルから、同期間中は13.4%のCAGRで推移し、2028年末には118億米ドルに達すると予測されています。機器の部門は、2023年の46億米ドルから、CAGR 11.6%で推移し、2028年末には80億米ドルに達すると予測されています。

当レポートでは、世界の出生前検査の市場を調査し、市場概要、法規制環境、市場影響因子および市場機会の分析、市場規模の推移・予測、各種区分・地域別の詳細分析、競合情勢、主要企業のプロファイルなどをまとめています。

目次

第1章 エグゼクティブサマリー

• 市場の展望
• 調査範囲
• 市場サマリー

第2章 市場概要

• 出生前検査
• 出生前検査の歴史
• もっとも一般的な染色体異常
• ダウン症候群
• 13トリソミーと18トリソミー
• 性染色体の違い
• 神経管欠損症
• 非侵襲的技術
• 非侵襲性出生前検査/細胞フリーDNAスクリーニング
• 母体血清スクリーニング検査
• 超音波検査
• その他
• 侵襲的技術
• 絨毛膜絨毛採取
• 羊水穿刺

第3章 市場力学

• 出生前検査市場に影響を与える要因
• 市場促進要因
• ダウン症の増加
• 希少遺伝性疾患の増加
• 出産年齢の上昇
• 技術の進歩
• 抑制要因
• 検査コストの高さ
• 偽陽性と偽陰性の結果
• 将来の機会
• 用途の拡大
• 新興市場
• 個別化医療
• 課題
• 規制上の障壁
• 一般の認識
• 非侵襲的出生前検査の適用範囲の課題：政策の不均衡

第4章 市場における新興技術と今後の技術

• 全ゲノムシーケンシングによるコピー数変異検出の強化
• 一塩基多型解析
• 全エクソームシーケンシング
• 高度画像技術
• 癌検出のための液体生検
• 出生前検査におけるAI

第5章 市場分析：各種区分別

• 市場規模：製品タイプ別
• 消耗品
• 機器
• 市場区分：技術別
• 概要
• 市場シェア
• 非侵襲的技術
• 侵襲的技術
• 市場区分：用途別
• 概要
• 市場シェア
• 神経管欠損症
• ダウン症候群
• 稀な遺伝性疾患
• その他
• 市場区分：エンドユーザー別
• 概要
• 市場シェア
• 診断検査室
• 病院
• 市場区分：地域的
• 概要
• 北米
• 欧州
• アジア太平洋
• その他の地域

第6章 競合情勢

• M&A・提携
• 出生前検査メーカーとサービスプロバイダーの市場シェア
• 特許レビュー・新たな開発
• 概要
• 特許分析：年別

第7章 ESG開発

• 産業界における出生前検査の持続可能性
• BCCによる見解

第8章 付録

• 調査手法
• 対象読者
• 略語
• 出典
• 企業プロファイル
• 10X GENOMICS
• AGILENT TECHNOLOGIES INC.
• BGI
• EUROFINS SCIENTIFIC
• F. HOFFMANN-LA ROCHE LTD.
• ILLUMINA INC.
• LABORATORY CORPORATION OF AMERICA HOLDINGS
• MEDICOVER GENETICS
• NATERA INC.
• QIAGEN
• QUEST DIAGNOSTICS INC.
• REVVITY INC.
• THERMO FISHER SCIENTIFIC INC.
• YOURGENE HEALTH

List of Tables

• Summary Table : Global Prenatal Testing Market, by Product, Through 2028
• Table 1 : Timeline of Technology Development of Prenatal Testing, 1956-2017
• Table 2 : Chance for Down Syndrome, by Age
• Table 3 : Price Per Prenatal Testing Strategy, 2021
• Table 4 : Global Prenatal Testing Market, by Product, Through 2028
• Table 5 : Global Consumables Products Market in Prenatal Testing, by Region, Through 2028
• Table 6 : Global Instruments Products Market in Prenatal Testing, by Region, Through 2028
• Table 7 : Global Prenatal Testing Market, by Technology, Through 2028
• Table 8 : Global Noninvasive Techniques Market in Prenatal Testing, by Type, Through 2028
• Table 9 : Global Noninvasive Prenatal Testing Market, by Region, Through 2028
• Table 10 : Global Maternal Serum Screening Market, by Region, Through 2028
• Table 11 : Global Ultrasound-Based Testing Market, by Region, Through 2028
• Table 12 : Global Others Noninvasive Techniques Market, by Region, Through 2028
• Table 13 : Global Invasive Techniques in Prenatal Testing Market, by Type, Through 2028
• Table 14 : Global Amniocentesis Invasive Techniques Market, by Region, Through 2028
• Table 15 : Global Chorionic Villus Sampling Invasive Techniques Market, by Region, Through 2028
• Table 16 : Global Others Invasive Techniques Market, by Region, Through 2028
• Table 17 : Global Prenatal Testing Market, by Application, Through 2028
• Table 18 : Global Neural Tube Defects Market in Prenatal Testing, by Region, Through 2028
• Table 19 : Global Down Syndrome Market in Prenatal Testing, by Region, Through 2028
• Table 20 : Global Rare Genetic Disorders Market in Prenatal Testing, by Region, Through 2028
• Table 21 : Global Other Application Market in Prenatal Testing, by Region, Through 2028
• Table 22 : Global Prenatal Testing Market, by End User, Through 2028
• Table 23 : Global Prenatal Testing Market in Diagnostic Laboratories, by Region, Through 2028
• Table 24 : Global Prenatal Testing Market in Hospitals, by Region, Through 2028
• Table 25 : Global Prenatal Testing Market, by Region, Through 2028
• Table 26 : North American Prenatal Testing Market, by Country, Through 2028
• Table 27 : European Prenatal Testing Market, by Country, Through 2028
• Table 28 : Asia-Pacific Prenatal Testing Market, by Country, Through 2028
• Table 29 : Mergers and Acquisitions: Prenatal Testing Manufacturers and Service Providers
• Table 30 : Patent Analysis, by Year, 2020-August 2023
• Table 31 : Major Patents in Prenatal Testing, by Applicant, 2023-February 2024
• Table 32 : ESG Highlights, by Major Players, 2022
• Table 33 : ESG Rankings of Major Companies Manufacturing Prenatal Testing, 2023
• Table 34 : Abbreviations
• Table 35 : Report Sources
• Table 36 : 10X Genomics: Company Snapshot
• Table 37 : 10X Genomics: Financial Performance, FY 2022 and 2023
• Table 38 : 10X Genomics: Product Portfolio
• Table 39 : 10X Genomics: News and Key Developments, 2023
• Table 40 : Agilent Technologies Inc.: Company Snapshot
• Table 41 : Agilent Technologies Inc.: Financial Performance, FY 2022 and 2023
• Table 42 : Agilent Technologies Inc.: Product Portfolio
• Table 43 : Agilent Technologies Inc.: News and Key Developments, 2020-2023
• Table 44 : BGI: Company Snapshot
• Table 45 : BGI Genomics: Product Portfolio
• Table 46 : BGI Genomics: News and Key Developments, 2023 and 2024
• Table 47 : Eurofins Scientific: Company Snapshot
• Table 48 : Eurofins Scientific: Financial Performance, FY 2022 and 2023
• Table 49 : Eurofins Scientific: Product Portfolio
• Table 50 : Eurofins Scientific: News and Key Developments, 2022
• Table 51 : F. Hoffmann-La Roche Ltd.: Company Snapshot
• Table 52 : F. Hoffmann-La Roche Ltd.: Financial Performance, FY 2022 and 2023
• Table 53 : F. Hoffmann-La Roche Ltd.: Product Portfolio
• Table 54 : F. Hoffmann-La Roche Ltd.: News and Key Developments, 2022 and 2023
• Table 55 : Illumina Inc.: Company Snapshot
• Table 56 : Illumina Inc.: Financial Performance, FY 2022 and 2023
• Table 57 : Illumina Inc.: Product Portfolio
• Table 58 : Illumina Inc.: News and Key Developments, 2022-2024
• Table 59 : Laboratory Corporation of America Holdings: Company Snapshot
• Table 60 : Laboratory Corporation of America Holdings: Financial Performance, FY 2022 and 2023
• Table 61 : Laboratory Corporation of America Holdings: Product Portfolio
• Table 62 : Laboratory Corporation of America Holdings: News and Key Developments, 2022-2024
• Table 63 : Medicover Genetics: Company Snapshot
• Table 64 : Medicover Genetics: Product Portfolio
• Table 65 : Medicover Genetics: News and Key Developments, 2022 and 2023
• Table 66 : Natera Inc.: Company Snapshot
• Table 67 : Natera Inc.: Financial Performance, FY 2021 and 2022
• Table 68 : Natera Inc.: Product Portfolio
• Table 69 : Natera Inc.: News and Key Developments, 2024
• Table 70 : Qiagen: Company Snapshot
• Table 71 : QIAGEN: Annual Financials/Revenue, 2021 and 2022
• Table 72 : Qiagen: Product Portfolio
• Table 73 : Qiagen: News and Key Developments, 2022-2024
• Table 74 : Quest Diagnostic Inc.: Company Snapshot
• Table 75 : Quest Diagnostic Inc.: Financial Performance, FY 2022 and 2023
• Table 76 : Quest Diagnostic Inc.: Product Portfolio
• Table 77 : Quest Diagnostic Inc.: News and Key Developments, 2021-2024
• Table 78 : Revvity Inc.: Company Snapshot
• Table 79 : Revvity Inc.: Financial Performance, FY 2021 and 2022
• Table 80 : Revvity Inc.: Product Portfolio
• Table 81 : Revvity Inc.: News and Key Developments, 2021-2023
• Table 82 : Thermo Fisher Scientific Inc.: Company Snapshot
• Table 83 : Thermo Fisher Scientific Inc.: Annual Financials/Revenue, 2021 and 2022
• Table 84 : Thermo Fisher Scientific Inc.: Product Portfolio
• Table 85 : Thermo Fisher Scientific Inc.: News and Key Developments, 2022 and 2023
• Table 86 : Yourgene Health: Company Snapshot
• Table 87 : Yourgene Health Product Portfolio
• Table 88 : Yourgene Health News/Key Developments, 2022 and 2023

List of Figures

• Summary Figure : Global Prenatal Testing Market, by Product, 2020-2028
• Figure 1 : Down Syndrome Karyotype
• Figure 2 : Market Dynamics: Global Prenatal Testing Market
• Figure 3 : Universal NIPT Coverage Across Payer Networks, 2020
• Figure 4 : Global Prenatal Testing Market, by Segment Analysis
• Figure 5 : Global Prenatal Testing Market, by Product, 2020-2028
• Figure 6 : Global Consumables Products Market in Prenatal Testing, by Region, 2020-2028
• Figure 7 : Global Instruments Products Market in Prenatal Testing, by Region, 2020-2028
• Figure 8 : Global Prenatal Testing Market, by Technology, 2020-2028
• Figure 9 : Global Noninvasive Techniques Market in Prenatal Testing, by Type, 2020-2028
• Figure 10 : Global Noninvasive Prenatal Testing Market, by Region, 2020-2028
• Figure 11 : Global Maternal Serum Screening Market, by Region, 2020-2028
• Figure 12 : Global Ultrasound-Based Testing Market, by Region, 2020-2028
• Figure 13 : Global Others Noninvasive Techniques Market, by Region, 2020-2028
• Figure 14 : Global Invasive Techniques in Prenatal Testing Market, by Type, 2020-2028
• Figure 15 : Global Amniocentesis Invasive Techniques Market, by Region, 2020-2028
• Figure 16 : Global Chorionic Villus Sampling Invasive Techniques Market, by Region, 2020-2028
• Figure 17 : Global Others Invasive Techniques Market, by Region, 2020-2028
• Figure 18 : Global Prenatal Testing Market, by Application, 2020-2028
• Figure 19 : Global Neural Tube Defects Market in Prenatal Testing, by Region, 2020-2028
• Figure 20 : Global Down Syndrome Market in Prenatal Testing, by Region, 2020-2028
• Figure 21 : Global Rare Genetic Disorders Market in Prenatal Testing, by Region, 2020-2028
• Figure 22 : Global Other Application Market in Prenatal Testing, by Region, 2020-2028
• Figure 23 : Global Prenatal Testing Market, by End User, 2020-2028
• Figure 24 : Global Prenatal Testing Market in Diagnostic Laboratories, by Region, 2020-2028
• Figure 25 : Global Prenatal Testing Market, in Hospitals, by Region, 2020-2028
• Figure 26 : Global Prenatal Testing Market, by Region, 2020-2028
• Figure 27 : Global Prenatal Testing Market Share, by Region, 2022
• Figure 28 : North American Prenatal Testing Market, by Country, 2020-2028
• Figure 29 : European Prenatal Testing Market, by Country, 2020-2028
• Figure 30 : Asia-Pacific Prenatal Testing Market, by Country, 2020-2028
• Figure 31 : Global Prenatal Testing Market Shares, by Key Manufacturers and Service Providers 2022
• Figure 32 : Published Patent Share, by Country, 2020-2023
• Figure 33 : Business Benefits of a Strong ESG Proposition
• Figure 34 : ESG-Adoption Level Across All the Industries, 2021 and 2022
• Figure 35 : 10 Business Sustainability Trends Identified for 2023
• Figure 36 : 10X Genomics: Revenue Share, by Business Unit, FY 2023
• Figure 37 : 10X Genomics: Revenue Share, by Country/Region, FY 2023
• Figure 38 : Agilent Technologies Inc.: Revenue Share, by Business Unit, FY 2023
• Figure 39 : Agilent Technologies Inc.: Revenue Share, by Country/Region, FY 2023
• Figure 40 : Eurofins Scientific: Revenue Share, by Country/Region, FY 2023
• Figure 41 : F. Hoffmann-La Roche Ltd.: Revenue Share, by Business Unit, FY 2023
• Figure 42 : F. Hoffmann-La Roche Ltd.: Revenue Share, by Country/Region, FY 2023
• Figure 43 : Illumina Inc.: Revenue Share, by Business Unit, FY 2022
• Figure 44 : Illumina Inc.: Revenue Share, by Country/Region, FY 2023
• Figure 45 : Laboratory Corporation of America Holdings: Revenue Share, by Business Unit, FY 2023
• Figure 46 : Laboratory Corporation of America Holdings: Revenue Share, by Country/Region, FY 2023
• Figure 47 : Natera Inc.: Revenue Share, by Business Unit, FY 2022
• Figure 48 : Natera Inc.: Revenue Share, by Country/Region, FY 2022
• Figure 49 : Qiagen: Revenue Share, by Business Unit, 2022
• Figure 50 : Qiagen: Revenue Share, by Region, 2022
• Figure 51 : Quest Diagnostic Inc.: Revenue Share, by Business Unit, FY 2023
• Figure 52 : Revvity Inc.: Revenue Share, by Business Unit, FY 2022
• Figure 53 : Revvity Inc.: Revenue Share, by Country/Region, FY 2022
• Figure 54 : Thermo Fisher Scientific Inc.: Revenue Share, by Business Unit, 2022
• Figure 55 : Thermo Fisher Scientific Inc.: Revenue Share, by Region, 2022

The global market for prenatal testing is expected to grow from $10.9 billion in 2023 and projected to reach $19.8 billion by the end of 2028, at a compound annual growth rate (CAGR) of 12.6% during the forecast period of 2023 to 2028.

The global market for consumables segment of prenatal testing is expected to grow from $6.3 billion in 2023 and projected to reach $11.8 billion by the end of 2028, at a CAGR of 13.4% during the forecast period of 2023 to 2028.

The global market for instruments segment of prenatal testing is expected to grow from $4.6 billion in 2023 and projected to reach $8.0 billion by the end of 2028, at a CAGR of 11.6% during the forecast period of 2023 to 2028.

Report Scope

The scope of the prenatal testing market is extensive and continually evolving, reflecting the dynamic landscape of technologies and methodologies employed to assess fetal health during pregnancy. Genetic testing plays a central role, encompassing a range of approaches from traditional invasive procedures, such as amniocentesis and chorionic villus sampling to modern noninvasive methods, such as noninvasive prenatal testing (NIPT). This market is characterized by its global reach, with varying levels of adoption and accessibility across different regions. The focus is predominantly on screening for genetic disorders, including chromosomal abnormalities and hereditary conditions. The rise of comprehensive testing strategies evaluating multiple biomarkers enhances diagnostic accuracy. The market is driven by increasing maternal age, heightened awareness of genetic disorders and technological advancements. Ongoing research and development (R&D) efforts continue to shape the scope of prenatal testing, with a strong emphasis on improving accuracy and accessibility and incorporating innovative diagnostic and screening procedures. It presents insights into current and future potential, drivers, challenges, opportunities, industry status, developments, market trends, geographical challenges and strategies (e.g., mergers, acquisitions, collaborations). The report informs all market players, potential entrants, government agencies and other interested parties. The report covers geographic regions in detail, so companies interested in expanding their geographic reach will also find this helpful study.

Report Includes

• 37 data tables and 52 additional tables
• An overview of the current and future global markets for prenatal testing
• Analyses of global market trends, with historical revenue data (sales figures) for 2021-2022, estimates for 2023, forecasts for 2024, and projected CAGRs through 2028
• Estimates of the current market size and revenue growth prospects, along with a market share analysis by technology and product types, application, end users and region
• Discussion of the market opportunities and challenges, ongoing R&D efforts and regulatory scenarios
• A look at emerging technologies related to prenatal testing
• Overview of the sustainability trends and ESG developments, with emphasis on consumer attitudes, companies' ESG rankings and their ESG practices
• Insight into the competitive landscape, including company market shares, financials and revenues
• Profiles of the leading players, including Illumina Inc., Laboratory Corporation of America Holdings, Thermo Fisher Scientific Inc., Natera Inc., and F. Hoffmann-La Roche Ltd.

Table of Contents

Chapter 1 Executive Summary

• Market Outlook
• Scope of Report
• Market Summary

Chapter 2 Market Overview

• Prenatal Testing
• History of Prenatal Testing
• Most Common Chromosomal Abnormalities
• Down Syndrome
• Trisomy 13 and Trisomy 18
• Sex Chromosome Differences
• Neural Tube Defects
• Noninvasive Techniques
• Noninvasive Prenatal Test/Cell-Free DNA Screening
• Maternal Serum Screening Test
• Ultrasound Testing
• Others
• Invasive Techniques
• Chorionic Villus Sampling
• Amniocentesis

Chapter 3 Market Dynamics

• Factors Affecting the Prenatal Testing Market
• Market Drivers
• Increase in Down Syndrome
• Increase in Rare Genetic Disorders
• Increasing Maternal Age
• Advancements in Technology
• Restraints
• High Cost of Testing
• False Positives and Negatives Results
• Future Opportunities
• Expanding Applications
• Emerging Markets
• Personalized Medicine
• Challenges
• Regulatory Hurdles
• Public Perception
• Noninvasive Prenatal Testing Coverage Challenges: Policy Disparities

Chapter 4 Emerging and Upcoming Technologies in the Market

• Introduction
• Enhancing Copy Number Variation Detection Through Whole-Genome Sequencing
• Single Nucleotide Polymorphisms Analysis
• Whole-Exome Sequencing
• Advanced Imaging Techniques
• Liquid Biopsy for Cancer Detection
• Artificial Intelligence in Prenatal Testing

Chapter 5 Market Segmentation Analysis

• Segmentation by Product Type
• Market Size
• Consumables
• Instruments
• Segmentation by Technology
• Overview
• Market Share
• Noninvasive Techniques
• Invasive Techniques
• Segmentation by Application
• Overview
• Market Share
• Neural Tube Defects
• Down Syndrome
• Rare Genetic Disorders
• Others
• Segmentation by End User
• Overview
• Market Share
• Diagnostic Laboratories
• Hospitals
• Geographic Breakdown
• Overview
• North America
• Europe
• Asia-Pacific
• Rest of the World

Chapter 6 Competitive Landscape

• Mergers, Acquisitions and Collaborations
• Prenatal Testing Manufacturers and Service Providers Market Shares
• Patent Review and New Developments
• Overview
• Patent Analysis by Year

Chapter 7 ESG Development

• Introduction
• Sustainability of Prenatal Testing in Industry
• BCC Research Viewpoint

Chapter 8 Appendix

• Methodology
• Intended Audience
• Abbreviations
• Sources
• Company Profiles
• 10X GENOMICS
• AGILENT TECHNOLOGIES INC.
• BGI
• EUROFINS SCIENTIFIC
• F. HOFFMANN-LA ROCHE LTD.
• ILLUMINA INC.
• LABORATORY CORPORATION OF AMERICA HOLDINGS
• MEDICOVER GENETICS
• NATERA INC.
• QIAGEN
• QUEST DIAGNOSTICS INC.
• REVVITY INC.
• THERMO FISHER SCIENTIFIC INC.
• YOURGENE HEALTH